SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Finkelstein JS, Neer RM, Biller BMK, Crawford JD, Klibanski A 1992 Osteopenia in men with a history of delayed puberty. N Engl J Med 326:600604.
  • 2
    Bass S, Delmas PD, Pearce G, Hendrich E, Tabensky A, Seeman E 1999 The differing tempo of growth in bone size, mass, and density in girls is region-specific. J Clin Invest 104:795804.
  • 3
    Issenman RM, Atkinson SA, Radoja C, Fraher L 1993 Longitudinal assessment of growth, mineral metabolism, and bone mass in pediatric Crohn's disease. J Pediatr Gastroenterol Nutr 17:401406.
  • 4
    Abitbol V, Roux C, Chaussade S, Guillemant S, Kolta S, Dougados M, Couturier D, Amor B 1995 Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 108:417422.
  • 5
    Jahnsen J, Falch JA, Aadland E, Mowinckel P 1997 Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: A population based study. Gut 40:313319.
  • 6
    Gokhale R, Favus MJ, Karrison T, Sutton MM, Rich B, Kirschner BS 1998 Bone Mineral Density Assessment in Children With Inflammatory Bowel Disease. Gastroenterology 114:902911.
  • 7
    Semeao EJ, Stallings VA, Peck SN, Piccoli DA 1997 Vertebral compression fractures in pediatric patients with Crohn's disease. Gastroenterology 112:17101713.
  • 8
    Ghosh S, Cowen S, Hannan WJ, Ferguson A 1994 Low bone mineral density in Crohn's disease, but not in ulcerative colitis, at diagnosis. Gastroenterology 107:10311039.
  • 9
    Hyams JS, Wyzga N, Kreutzer DL, Justinich CJ, Gronowicz GA 1997 Alterations in bone metabolism in children with inflammatory bowel disease: An in vitro study. J Pediatr Gastroenterol Nutr 24:289295.
  • 10
    Lin C-L, Moniz C, Chambers TJ, Chow JWM 1996 Colitis causes bone loss in rats through suppression of bone formation. Gastroenterology 111:12631271.
  • 11
    Manolagas SC, Jilka RL 1995 Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis. N Engl J Med 332:305311.
  • 12
    Stevens C, Walz G, Singaram C, Lipman ML, Zanker B, Muggia A, Antonioli D, Peppercorn MA, Strom TB 1992 Tumor necrosis factor-α, interleukin-1β, and interleukin-6 expression in inflammatory bowel disease. Dig Dis Sci 37:818826.
  • 13
    Reinecker HC, Steffen M, Witthoeft T, Pflueger I, Schreiber S, Mac Dermott RP, Raedler A 1993 Enhanced secretion of tumour necrosis factor-alpha, IL-6, and Il-1β by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease. Clin Exp Immunol 94:174181.
  • 14
    Mahida YR, Kurlac L, Gallagher A, Hawkey CJ 1991 High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis. Gut 32:15311534.
  • 15
    Hyams JS, Fitzgerald JE, Treem WR, Wyzga N, Kreutzer DL 1993 Relationship of functional and antigenic interleukin-6 to disease activity in inflammatory bowel disease. Gastroenterology 104:12851292.
  • 16
    Bross DA, Leichtner AM, Zurakowski D, Law T, Bousvaros A 1996 Elevation of serum interleukin-6 but not serum-soluble interleukin-2 receptor in children with Crohn's disease. J Pediatr Gastroenterol Nutr 23:164171.
  • 17
    Pollak RD, Karmeli F, Eliakim R, Ackerman Z, Tabb K, Rachmilevitz D 1998 Femoral neck osteopenia in patients with inflammatory bowel disease. Am J Gastroenterol 93:14831490.
  • 18
    Manolagas SC, Jilka RL, Bellido T, O'Brien CA, Parfitt AM 1996 Interleukin-6 type cytokines and their receptors. In: BilezikianJP, RaiszLG, RodanGA (eds.) Principles of Bone Biology. Academic Press, News York, NY, USA, pp. 701713.
  • 19
    Franchimont N, Rydziel S, Delany AM, Canalis E 1997 Interleukin-6 and its soluble receptor cause a marked induction of collagenase 3 expression in rat osteoblast cultures. J Biol Chem 272:1214412150.
  • 20
    Littlewood AJ, Russell J, Harvey GR, Hughes DE, Russell RGG, Gowen M 1991 The modulation of the expression of IL-6 and its receptor in human osteoblasts in vitro. Endocrinology 129:15131520.
  • 21
    Kurokouchi K, Kambe F, Yasukawa K, Izumi R, Ishiguro N, Iwata H, Seo H 1998 TNF-α increases expression of IL-6 and ICAM-1 genes through activation of NF-κB in osteoblast-like ROS17/2.8 cells. J Bone Miner Res 13:12901299.
  • 22
    Franchimont N, Rydziel S, Canalis E 1997 Interleukin 6 is autoregulated by transcriptional mechanisms in cultures of rat osteoblastic cells. J Clin Invest 100:17971803.
  • 23
    Alonzi T, Fattori E, Lazzaro D, Costa P, Probert L, Kollias G, De Benedetti F, Poli V, Ciliberto G 1998 Interleukin 6 is required for the development of collagen-induced arthritis. J Exp Med 187:461468.
  • 24
    Ohshima S, Saeki Y, Mima T, Sasai M, Nishioka K, Nomura S, Kopf M, Katada Y, Tanaka T, Suemura M, Kishimoto T 1998 Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc Natl Acad Sci USA 95:82228226.
  • 25
    Bataille R, Jourdan M, Zhang X-G, Klein B 1989 Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias. J Clin Invest 84:20082011.
  • 26
    Hoyland JA, Freemont AJ, Sharpe PT 1994 Interleukin-6, IL-6 receptor, and IL-6 nuclear factor gene expression in Paget's disease. J Bone Miner Res 9:7580.
  • 27
    Jilka RL 1998 Cytokines, bone remodeling, and estrogen deficiency: A 1998 update. Bone 23:7581.
  • 28
    Greenwald RA, Stein B, Miller F 1998 Rapid skeletal turnover and hypercalcemia associated with markedly elevated interleukin-6 levels in a young black man. Bone 22:285288.
  • 29
    Devlin RD, Bone HG III, Roodman GD 1996 Interleukin-6: A potential mediator of the massive osteolysis in patients with Gorham-Stout disease. J Clin Endocrionol Metab 81:18931897.
  • 30
    Gronowicz G, Woodiel FN, McCarthy MB, Raisz LG 1989 In vitro mineralization of fetal rat parietal bones in defined serum-free medium: Effect of beta-glycerol phosphate. J Bone Miner Res 4:313324.
  • 31
    Hyams JS, Ferry GD, Mandel FS, Gryboski JD, Kibort PM, Kirschner BS, Griffiths AM, Katz AJ, Boyle JT, Michener WM, Levy JS, Lesser ML 1991 Development and validation of a pediatric Crohn's disease activity index. J Pediatr Gastroenterol Nutr 12:439447.
  • 32
    Hyams JS, Hyman PE 1998 Recurrent abdominal pain and the biopsychosocial model of medical practice. J Pediatr 133:473478.
  • 33
    Peterkofsky B, Diegelman R 1971 Use of a mixture of proteinase-free collagenases for the specific assay of radioactive collagen in the presence of other proteins. Biochemistry 10:988994.
  • 34
    Peterkofsky B, Diegelman R 1972 Collagen biosynthesis during connective tissue development in chick embryo. Dev Biol 28:443453.
  • 35
    Brunk CF, Jones KC, James TW 1979 Assay for nanogram quantities of dna in cellular homogenates. Anal Biochem 92:497500.
  • 36
    Satsangi J, Wolstencroft RA, Cason J, Ainley CC, Dumonde DC, Thompson RPH 1987 Interleukin 1 in Crohn's disease. Clin Exp Immunol 67:594605.
  • 37
    Hyams JS, Treem WR, Eddy E, Wyzga N, Moore RE 1991 Tumor necrosis factor-α is not elevated in children with inflammatory bowel disease. J Pediatr Gastroenterol Nutr 12:233236.
  • 38
    Murch SH, Lamkin VA, Savage MO, Walker-Smith JA, MacDonald TT 1991 Serum concentrations of tumour necrosis factor α in childhood chronic inflammatory bowel disease. Gut 32:913917.
  • 39
    Hughes FJ, Howells GL 1993 Interleukin-6 inhibits bone formation in vitro. Bone Miner 21:2128.
  • 40
    Fang MA, Hahn TJ 1991 Effects of interleukin-6 on cellular function in UMR-106–01 osteoblastlike cells. J Bone Miner Res 6:133139.
  • 41
    Franchimont N, Gangji V, Durant D, Canalis E 1997 Interleukin-6 with its soluble receptor enhances the expression of insulin-like growth factor-i in osteoblasts. Endocrinology 138:52485255.
  • 42
    Franchimont N, Durant D, Canalis E 1997 Interleukin-6 and its soluble receptor regulate the expression of insulin-like growth factor binding protein-5 in osteoblast cultures. Endocrinology 138:33803386.
  • 43
    Littlewood AJ, Aarden LA, Evans DB, Russell RG, Gowen M 1991 Human osteoblastlike cells do not respond to interleukin-6. J Bone Miner Res 6:141148.
  • 44
    Kim C-H, Cheng S-L, Him GS 1997 Lack of autocrine effects of IL-6 on human bone marrow stromal osteoprogenitor cells. Endocr Res 23:181190.
  • 45
    Poli V, Balena R, Fattori E, Markatos A, Yamamoto M, Tanaka H, Ciliberto G, Rodan GA, Costantini F 1994 Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J 13:11891196.
  • 46
    Bellido T, Jilka RL, Boyce BF, Girasole G, Broxmeyer H, Dalrymple SA, Murray R, Manolagas SC 1995 Regulation of interleukin-6, osteoclastogenesis, and bone mass by androgens. The role of the androgen receptor. J Clin Invest 95:28862895.
  • 47
    Vargas SJ, Naprta A, Lee SK, Kalinowski J, Kawaguchi H, Pilbeam CC, Raisz LG, Lorenzo JA 1996 Lack of evidence for an increase in interleukin-6 expression in adult murine bone, bone marrow, and marrow stromal cell cultures after ovariectomy. J Bone Miner Res 11:19261934.
  • 48
    De Benedetti F, Pignatti P, Vivarelli M, Meazza C, Ciliberto G, Savino R, Martini A 2001 In vivo neutralization of human IL-6 (hIL-6) achieved by immunization of hIL-6 transgenic mice with a hIL-6 receptor antagonist. J Immunol 166:43344340.
  • 49
    Kitamura H, Kawata H, Takahashi F, Higuchi Y, Furuichi T, Ohkawa H 1995 Bone marrow neutrophilia and suppressed bone turnover in human interleukin-6 transgenic mice. Am J Pathol 147:16821692.
  • 50
    Dai J, Lin D, Zhang J, Habib P, Smith P, Murtha J, Fu Z, Yao Z, Qi Y, Keller ET 2000 Chronic alcohol ingestion induces osteoclastogenesis and bone loss through IL-6 in mice. J Clin Invest 106:887895.
  • 51
    Baker PJ, Dixon M, Evans RT, Dufour L, Johnson E, Roopenian DC 1999 CD4+ T cells and the proinflammatory cytokines gamma interferon and interleukin-6 contribute to alveolar bone loss in mice. Infect Immun 67:28042809.
  • 52
    Gronowicz GA, Derome ME 1994 Synthetic peptide containing Arg-Gly-Asp inhibits bone formation and resorption in a mineralizing organ culture system of fetal rat parietal bones. J Bone Miner Res 9:193201.